Latest news with #WorldOvarianCancerCoalition
Yahoo
09-05-2025
- Health
- Yahoo
Advocates raise awareness for ovarian cancer in Fairmont
FAIRMONT, (WBOY) — May 8 is World Ovarian Cancer Awareness Day, and in Fairmont, advocates took time to hang teal balloons in front of the courthouse to raise awareness of the disease. The teal balloons have become something of a tradition for Kelli Bledsoe, an ovarian cancer survivor whose mother passed from the disease, as this is the fourth year that she's hung up the balloons. 'The more I can tell people about ovarian cancer and what to do,' Bledsoe told 12 News. 'The more lives we can save. The earlier detection, more lives saved.' Man who fell from stands at Pittsburgh Pirates game speaks out: 'I'm all right' The World Ovarian Cancer Coalition reported in 2020 that 200,000 women died of the disease that year and that it's tricky to recognize ovarian cancer as its symptoms, like bloating and abdominal pain, can be mistaken for other ailments. Advocates in Fairmont called for the public to get genetically tested for ovarian cancer in order to help with early detection. Mutations to the BRCA1 and BRCA2 genes are known to lead to an increased risk of ovarian and breast cancer. The World Ovarian Cancer Coalition has reported that up to 25% of those diagnosed with ovarian cancer had a hereditary tendency to develop the disease. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
National Post
08-05-2025
- Health
- National Post
World Ovarian Cancer Coalition Launches Global Expert Advisory Group on Ovarian Cancer
Article content Article content TORONTO — On World Ovarian Cancer Day (#WOCD2025), the World Ovarian Cancer Coalition (the Coalition) announces the formation of the Global Expert Advisory Group on Ovarian Cancer, a new initiative to elevate ovarian cancer as a global health priority. Article content On World Ovarian Cancer Day (#WOCD2025), the World Ovarian Cancer Coalition announces the formation of the Global Expert Advisory Group on Ovarian Cancer, a new initiative to elevate ovarian cancer as a global health priority. Article content Ovarian cancer is the most lethal of female cancers. With no reliable screening test, low awareness and significant diagnostic barriers, millions of lives are at stake – particularly in low- and middle-income countries where the burden is disproportionately high. Without urgent action, the world could lose eight million women to ovarian cancer by 2050. Article content The newly formed Global Expert Advisory Group on Ovarian Cancer brings together patient advocates, leading clinicians and policy makers from 13 nations across six continents. The group's mission is to develop a comprehensive framework for a global ovarian cancer strategy that will have an impact at country level to ensure that everyone living with, or at risk of, ovarian cancer has the best chance of survival and the best quality of life possible, no matter where they live. The group has identified three critical areas of focus: Article content Building Community and Policymaker Awareness Optimising Routes to Diagnosis Access to Services and Treatment for Hereditary Ovarian Cancer Article content The Group is chaired by World Ovarian Cancer Coalition Board Member (and past Chair) Annwen Jones OBE and Assoc. Professor Tracey Adams, a Gynaecological Oncologist at Groote Schuur Hospital University of Cape Town, South Africa. 'This is a global challenge that demands a global response,' said the Co-Chairs. 'Alongside the key areas of focus, we plan to set a target for a reduction in global ovarian cancer mortality in a similar vein to the global breast cancer initiative.' Article content The announcement builds on findings from the Coalition's recent studies: the Socioeconomic Burden of Ovarian Cancer in 11 Countries and the groundbreaking Every Woman Study™: Low- and Middle-Income Edition. These studies revealed: Article content The Group's members are: Article content Dr. Carlos Andrade, Assistant at Gynecologic Oncology Department, Barretos Cancer Hospítal (Brazil) Dr. Garth Funston, Lecturer, Wolfson Institute of Population Health (UK) Nimkee Gupta, Patient advocate (India and Luxembourg) Jennifer Hollington, Retired assistant deputy minister in the Government of Canada, Patient advocate (Canada) Dilyara Kaidarova, MD, PhD, Prof., First Vice-Rector, Asfendiyarov Kazakh National Medical University (Kazakhstan) Bar Levy, CEO, HaBait Shel Bar- Israel's Women's Cancer Association, Patient Advocate (Israel) Prof. Ranjit Manchanda, Professor of Gynaecological Oncology, Wolfson Institute of Population Health (UK) Prof. Ursula Matulonis, Chief, Division of Gynecologic Oncology, Dana-Farber Cancer Institute (US) Dr. Asima Mukhopadhyay, Founder and Director, KolGOTrg, Gynaecological Oncologist/Surgeon, James Cook University Hospital and Newcastle University (India and UK) Dr. Aisha Mustapha, Consultant Obstetrician Gynaecologist, Ahmadu Bello University (Nigeria) Dr. Florencia Noll, Head of Unit, Sanatario Allende Cerro (Argentina) Prof. Amit Oza, Head, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre (Canada) Sarah Powell, CEO, Inherited Cancers Australia (Australia) Prof. Basel Refky, Oncology Center, Mansoura University (Egypt) Dr. Ritu Salani, Professor, Department of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA (US) Sbba Siddique, Patient advocate (UK) Prof. Sudha Sundar, Gynaecological oncology, University of Birmingham (UK) Carolyn Taylor, Founder & Executive Director, Global Focus on Cancer (US) Dr. Julie Torode, Director Strategic Partnerships, Patient and Community Engagement, Institute of Cancer Policy, Kings College of London, and Board Member, World Ovarian Cancer Coalition (Switzerland and UK) Article content Article content Article content Article content Article content Contacts Article content Media contacts: Annabel Deegan media@ Article content Article content Article content
Business Wire
08-05-2025
- Health
- Business Wire
World Ovarian Cancer Coalition Launches Global Expert Advisory Group on Ovarian Cancer
TORONTO--(BUSINESS WIRE)--On World Ovarian Cancer Day (#WOCD2025), the World Ovarian Cancer Coalition (the Coalition) announces the formation of the Global Expert Advisory Group on Ovarian Cancer, a new initiative to elevate ovarian cancer as a global health priority. On World Ovarian Cancer Day (#WOCD2025), the World Ovarian Cancer Coalition announces the formation of the Global Expert Advisory Group on Ovarian Cancer, a new initiative to elevate ovarian cancer as a global health priority. Share Ovarian cancer is the most lethal of female cancers. With no reliable screening test, low awareness and significant diagnostic barriers, millions of lives are at stake - particularly in low- and middle-income countries where the burden is disproportionately high. Without urgent action, the world could lose eight million women to ovarian cancer by 2050. The newly formed Global Expert Advisory Group on Ovarian Cancer brings together patient advocates, leading clinicians and policy makers from 13 nations across six continents. The group's mission is to develop a comprehensive framework for a global ovarian cancer strategy that will have an impact at country level to ensure that everyone living with, or at risk of, ovarian cancer has the best chance of survival and the best quality of life possible, no matter where they live. The group has identified three critical areas of focus: Building Community and Policymaker Awareness Optimising Routes to Diagnosis Access to Services and Treatment for Hereditary Ovarian Cancer The Group is chaired by World Ovarian Cancer Coalition Board Member (and past Chair) Annwen Jones OBE and Assoc. Professor Tracey Adams, a Gynaecological Oncologist at Groote Schuur Hospital University of Cape Town, South Africa. 'This is a global challenge that demands a global response,' said the Co-Chairs. 'Alongside the key areas of focus, we plan to set a target for a reduction in global ovarian cancer mortality in a similar vein to the global breast cancer initiative.' The announcement builds on findings from the Coalition's recent studies: the Socioeconomic Burden of Ovarian Cancer in 11 Countries and the groundbreaking Every Woman Study™: Low- and Middle-Income Edition. These studies revealed: Exceptionally low awareness of ovarian cancer among women globally Lack of knowledge about genetic risk including the BRCA1 and BRCA2 mutations The huge socioeconomic burden of the disease on families, healthcare systems and national economies The Group's members are: Dr. Carlos Andrade, Assistant at Gynecologic Oncology Department, Barretos Cancer Hospítal (Brazil) Dr. Garth Funston, Lecturer, Wolfson Institute of Population Health (UK) Nimkee Gupta, Patient advocate (India and Luxembourg) Jennifer Hollington, Retired assistant deputy minister in the Government of Canada, Patient advocate (Canada) Dilyara Kaidarova, MD, PhD, Prof., First Vice-Rector, Asfendiyarov Kazakh National Medical University (Kazakhstan) Bar Levy, CEO, HaBait Shel Bar- Israel's Women's Cancer Association, Patient Advocate (Israel) Prof. Ranjit Manchanda, Professor of Gynaecological Oncology, Wolfson Institute of Population Health (UK) Prof. Ursula Matulonis, Chief, Division of Gynecologic Oncology, Dana-Farber Cancer Institute (US) Dr. Asima Mukhopadhyay, Founder and Director, KolGOTrg, Gynaecological Oncologist/Surgeon, James Cook University Hospital and Newcastle University (India and UK) Dr. Aisha Mustapha, Consultant Obstetrician Gynaecologist, Ahmadu Bello University (Nigeria) Dr. Florencia Noll, Head of Unit, Sanatario Allende Cerro (Argentina) Prof. Amit Oza, Head, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre (Canada) Sarah Powell, CEO, Inherited Cancers Australia (Australia) Prof. Basel Refky, Oncology Center, Mansoura University (Egypt) Dr. Ritu Salani, Professor, Department of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA (US) Sbba Siddique, Patient advocate (UK) Prof. Sudha Sundar, Gynaecological oncology, University of Birmingham (UK) Carolyn Taylor, Founder & Executive Director, Global Focus on Cancer (US) Dr. Julie Torode, Director Strategic Partnerships, Patient and Community Engagement, Institute of Cancer Policy, Kings College of London, and Board Member, World Ovarian Cancer Coalition (Switzerland and UK) About the World Ovarian Cancer Coalition The World Ovarian Cancer Coalition, the only global not-for-profit organization focused solely on ovarian cancer, was established in 2016 and comprises over 200 patient advocacy group members in 37 countries. We work globally to ensure that everyone living with, or at risk of, ovarian cancer has the best chance of survival and the best quality of life, no matter where they live. To learn more, visit our website and follow us on LinkedIn, Facebook, Instagram, X and YouTube.
National Post
05-05-2025
- Health
- National Post
World Ovarian Cancer Coalition Leads Global Campaign to Raise Awareness of Ovarian Cancer
Article content TORONTO — World Ovarian Cancer Day (#WOCD2025) is May 8th, when the World Ovarian Cancer Coalition and its 200 partner organizations from around the globe raise their collective voices to increase awareness of ovarian cancer and advocate for the global health community to recognise ovarian cancer as a health priority and boost crucial awareness efforts in order to save lives. Article content World Ovarian Cancer Coalition Global Ambassador and best-selling novelist, Deborah Harkness says, 'If your body is telling you something isn't right, LISTEN TO IT. I urge women to know the signs of ovarian cancer, make sure that you take this list of symptoms to your doctor to advocate for the right testing and the right follow-through care. Women and their doctors must be better informed about the symptoms of ovarian cancer so that they can take action. If we do this, we will truly leave no woman behind in the challenge of facing ovarian cancer.' Article content What women should know: Article content The five most common symptoms of ovarian cancer: Article content Persistent bloating Difficulty eating Feeling full quickly Pelvic/abdominal pain Urinary changes Article content Our Every Woman Study TM: Low-and Middle-Income Edition, which documented the experiences of over 2400 women living with ovarian cancer in 22 low- and middle-income countries (LMIC), found that just one in four women (26.1%) said they had heard of ovarian cancer and knew something about it prior to their own diagnosis. This varied by country from as low as 3.3% (Nepal) to 63.2% (Uzbekistan). This stark lack of awareness is not just the case for LMICs. According to our first Every Woman Study in 2018, over two-thirds of women in high-income countries had not heard of ovarian cancer or knew anything about it prior to their own diagnosis. There is a direct link between awareness and diagnosis. The 2018 study revealed that women with more knowledge of ovarian cancer were more likely to visit their doctor within three months. Article content #WOCD2025 theme is 'No Woman Left Behind' Article content World Ovarian Cancer Coalition CEO, Clara MacKay says, 'No matter where she lives, every woman with ovarian cancer deserves the earliest possible diagnosis and the best possible care. Accelerating diagnosis efforts and radically boosting awareness is not just a global health and economic imperative – it's a matter of equality and justice.' Article content If action is not taken to change the status quo, 12 million women will be diagnosed with ovarian cancer and eight million women will die from the disease by 2050. Ovarian cancer must be integrated into global women's health initiatives and National Cancer Control Plans to change these stats. Article content Now in its 13th year, World Ovarian Cancer Day unites individuals and organizations to raise awareness about ovarian cancer and advocate for better care and treatment for those affected by the disease. To help support #WOCD2025, see the Get Involved Guide for social media artwork and other digital assets. Follow the Coalition on Instagram, Facebook, and LinkedIn. Article content Article content Article content Article content Article content Contacts Article content Article content Article content
Business Wire
05-05-2025
- Health
- Business Wire
World Ovarian Cancer Coalition Leads Global Campaign to Raise Awareness of Ovarian Cancer
TORONTO--(BUSINESS WIRE)-- World Ovarian Cancer Day (#WOCD2025) is May 8th, when the World Ovarian Cancer Coalition and its 200 partner organizations from around the globe raise their collective voices to increase awareness of ovarian cancer and advocate for the global health community to recognise ovarian cancer as a health priority and boost crucial awareness efforts in order to save lives. On May 8, #WorldOvarianCancerDay, join us in raising our voices to increase awareness of the disease and advocate to make ovarian cancer a global health priority. Low awareness of the symptoms and risks delays diagnosis and treatment. #NoWomanLeftBehind Share World Ovarian Cancer Coalition Global Ambassador and best-selling novelist, Deborah Harkness says, 'If your body is telling you something isn't right, LISTEN TO IT. I urge women to know the signs of ovarian cancer, make sure that you take this list of symptoms to your doctor to advocate for the right testing and the right follow-through care. Women and their doctors must be better informed about the symptoms of ovarian cancer so that they can take action. If we do this, we will truly leave no woman behind in the challenge of facing ovarian cancer.' What women should know: The five most common symptoms of ovarian cancer: Persistent bloating Difficulty eating Feeling full quickly Pelvic/abdominal pain Urinary changes Lack of knowledge of ovarian cancer creates significant delays in diagnosis and starting treatment Our Every Woman Study TM: Low-and Middle-Income Edition, which documented the experiences of over 2400 women living with ovarian cancer in 22 low- and middle-income countries (LMIC), found that just one in four women (26.1%) said they had heard of ovarian cancer and knew something about it prior to their own diagnosis. This varied by country from as low as 3.3% (Nepal) to 63.2% (Uzbekistan). This stark lack of awareness is not just the case for LMICs. According to our first Every Woman Study in 2018, over two-thirds of women in high-income countries had not heard of ovarian cancer or knew anything about it prior to their own diagnosis. There is a direct link between awareness and diagnosis. The 2018 study revealed that women with more knowledge of ovarian cancer were more likely to visit their doctor within three months. #WOCD2025 theme is 'No Woman Left Behind' World Ovarian Cancer Coalition CEO, Clara MacKay says, 'No matter where she lives, every woman with ovarian cancer deserves the earliest possible diagnosis and the best possible care. Accelerating diagnosis efforts and radically boosting awareness is not just a global health and economic imperative - it's a matter of equality and justice.' If action is not taken to change the status quo, 12 million women will be diagnosed with ovarian cancer and eight million women will die from the disease by 2050. Ovarian cancer must be integrated into global women's health initiatives and National Cancer Control Plans to change these stats. Now in its 13th year, World Ovarian Cancer Day unites individuals and organizations to raise awareness about ovarian cancer and advocate for better care and treatment for those affected by the disease. To help support #WOCD2025, see the Get Involved Guide for social media artwork and other digital assets. Follow the Coalition on Instagram, Facebook, and LinkedIn.
